title: [Clinical and laboratory evaluation of 20% albumin (plasbumin) used in cardiosurgical patients].
abstract: A randomized comparative study of the effect of 20% Albumin (Plasbumin) solution and 4% succinylated gelatin (helofusin) solution on homeostasis was conducted in 36 cardiosurgical patients when the solutions were used as components to fill a pump oxygenator (PO). A comparative analysis has indicated that the use of albumin in the primary volume of PO at a concentration of 2-3% provides a higher level of total protein and better maintains colloid osmotic pressure during extracorporeal circulation than that of helofusin. At the end of an operation, the oxygen index was higher in the patients given albumin (Plasbumin). It has been also ascertained that plasbumin is well tolerated, causes no adverse reactions, and produces no dose-dependent effect.
authors.forename: N A
authors.initials: NA
authors.lastname: Trekova
authors.forename: B A
authors.initials: BA
authors.lastname: Aksel'rod
authors.forename: G V
authors.initials: GV
authors.lastname: Babalian
authors.forename: S V
authors.initials: SV
authors.lastname: Zaĭtseva
authors.forename: I I
authors.initials: II
authors.lastname: Dement'eva
authors.forename: A A
authors.initials: AA
authors.lastname: Buniatian
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D006348:Cardiac Surgical Procedures; D015199:Extracorporeal Membrane Oxygenation / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010952:Plasma Substitutes / Q000008:administration & dosage / Q000627:therapeutic use*; D011097:Polygeline / Q000008:administration & dosage / Q000627:therapeutic use*; D011184:Postoperative Period; D012709:Serum Albumin / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D010952:Plasma Substitutes; D012709:Serum Albumin; D011097:Polygeline